UNITED THERAPEUTICS (UTHR) CFO exercises 10K options, sells 10K shares under 10b5-1 plan
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond exercised stock options and sold shares in a pre-planned transaction. On April 9, 2026, he exercised options for 10,000 shares of Common Stock at an exercise price of $135.42 per share.
On the same date, he sold a total of 10,000 shares of Common Stock in multiple open-market trades at prices reported between about $574.18 and $582.30. These transactions were made under a Rule 10b5-1 trading plan entered into on October 31, 2025, indicating they were pre-scheduled.
Following the transactions, Edgemond directly owned 18,876 shares of UNITED THERAPEUTICS Common Stock, maintaining a meaningful equity stake while monetizing the shares received from the option exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.42M approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.78M)
Approx. gross sale proceeds
$5.78M
Approx. exercise cost
$1.35M
Approx. pre-tax spread
$4.42M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $135.42 | $1.35M |
| Sale | Common Stock | 560 | $574.868 | $322K |
| Sale | Common Stock | 1,956 | $575.5272 | $1.13M |
| Sale | Common Stock | 1,586 | $576.6268 | $915K |
| Sale | Common Stock | 1,617 | $577.7654 | $934K |
| Sale | Common Stock | 1,139 | $578.5244 | $659K |
| Sale | Common Stock | 1,224 | $579.7491 | $710K |
| Sale | Common Stock | 1,756 | $580.6392 | $1.02M |
| Sale | Common Stock | 162 | $582.3023 | $94K |
Holdings After Transaction:
Stock Option — 102,500 shares (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (9)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $574.18 to $575.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $575.18 to $576.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $576.18 to $577.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $577.19 to $578.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $578.22 to $579.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $579.24 to $580.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $580.24 to $581.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $581.25 to $581.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 10,000 shares
Exercise price: $135.42 per share
Shares sold: 10,000 shares
+4 more
7 metrics
Options exercised
10,000 shares
Stock option exercise into Common Stock on April 9, 2026
Exercise price
$135.42 per share
Exercise price of stock options converted on April 9, 2026
Shares sold
10,000 shares
Total Common Stock sold in open-market trades on April 9, 2026
Example sale price
$574.868 per share
One tranche of 560 shares of Common Stock sold
Highest reported sale price
$582.3023 per share
Tranche of 162 shares of Common Stock sold
Shares held after
18,876 shares
Direct Common Stock ownership following all April 9, 2026 trades
Rule 10b5-1 plan date
October 31, 2025
Date the trading plan governing these transactions was entered
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did UNITED THERAPEUTICS (UTHR) CFO James Edgemond report in this Form 4?
CFO James Edgemond reported exercising options for 10,000 UNITED THERAPEUTICS shares and selling 10,000 shares on April 9, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan and left him holding 18,876 shares directly.
What overall pattern does the UNITED THERAPEUTICS (UTHR) Form 4 show for the CFO?
The Form 4 shows an exercise-and-sell pattern: 10,000 options exercised at $135.42, then 10,000 shares sold at market prices around the high-$570s to low-$580s, executed under a Rule 10b5-1 trading plan, with 18,876 shares retained.